These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Granulocyte-macrophage colony-stimulating factor and marrow transplantation. Sauter C N Engl J Med; 1988 Sep; 319(13):870-1. PubMed ID: 3045556 [No Abstract] [Full Text] [Related]
7. Effects of recombinant human granulocyte-colony stimulating factor on hematopoietic reconstitution after autologous bone marrow transplantation in primates. Gillio AP; Bonilla MA; Potter GK; Gabrilove JL; O'Reilly RJ; Souza LM; Welte K Transplant Proc; 1987 Dec; 19(6 Suppl 7):153-6. PubMed ID: 3321642 [No Abstract] [Full Text] [Related]
8. Recombinant granulocyte/macrophage-colony stimulating factor in human and murine bone marrow transplantation. Blazar BR; Widmer MB; Kersey JH; Ramsay NK; McGlave PB; Urdal DL; Gillis S; Henney C; Vallera DA Behring Inst Mitt; 1988 Aug; (83):170-80. PubMed ID: 3071335 [TBL] [Abstract][Full Text] [Related]
9. The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation. Peters WP; Kurtzberg J; Atwater S; Borowitz M; Rao M; Currie M; Gilbert C; Shpall EJ; Jones RB; Ross M Prog Clin Biol Res; 1990; 338():121-8. PubMed ID: 2189135 [No Abstract] [Full Text] [Related]
10. Recombinant human granulocyte-macrophage colony stimulating factor (rh GM-CSF) after bone marrow transplantation. Link H; Freund M; Kirchner H; Stoll M; Schmid H; Bucsky P; Seidel J; Schulz G; Schmidt RE; Riehm H Behring Inst Mitt; 1988 Aug; (83):313-9. PubMed ID: 3071346 [TBL] [Abstract][Full Text] [Related]
11. Biological molecules in the treatment of hematological disorders. Kurzrock R; Talpaz M; Gutterman U Sangre (Barc); 1989 Feb; 34(1):53-8. PubMed ID: 2469130 [No Abstract] [Full Text] [Related]
12. [Recent progress in the treatment of hematological malignancies. III. Acute leukemia--treatment with cytokines]. Urushizaki I; Takaku F Nihon Naika Gakkai Zasshi; 1989 Jun; 78(6):781-4. PubMed ID: 2477477 [No Abstract] [Full Text] [Related]
16. [Recent progress in the treatment of hematological malignancies. III. Management of patients with myelodysplastic syndromes and atypical leukemias]. Yoshida Y Nihon Naika Gakkai Zasshi; 1989 Jun; 78(6):785-8. PubMed ID: 2507717 [No Abstract] [Full Text] [Related]
17. Different response to recombinant human granulocyte-macrophage colony-stimulating factor in primary and secondary graft failure after bone marrow transplantation. Sierra J; Terol MJ; Urbano-Ispizua A; Rovira M; Marin P; Carreras E; Batlle M; Rozman C Exp Hematol; 1994 Jul; 22(7):566-72. PubMed ID: 8013572 [TBL] [Abstract][Full Text] [Related]
18. Treatment of minimal residual disease in acute leukemia--focus on immunotherapeutic options. Simonsson B; Nilsson BI; Rowe JM Leukemia; 1992 Nov; 6 Suppl 4():124-34. PubMed ID: 1279326 [No Abstract] [Full Text] [Related]
19. Effects of granulocyte-macrophage colony-stimulating factor in iatrogenic myelosuppression, bone marrow failure, and regulation of host defense. Gutterman J; Vadhan-Raj S; Logothetis C; Anaissle E; Estey E; Talpaz M; Kurzrock R Semin Hematol; 1990 Jul; 27(3 Suppl 3):15-24. PubMed ID: 2198660 [TBL] [Abstract][Full Text] [Related]